Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

By LabMedica International staff writers
Posted on 23 May 2024

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. More...

These conditions are caused by the clumping together of the smallest building blocks in the body that disrupts vital functions. Within our cells, numerous interactions and exchanges among proteins and other molecules occur naturally, allowing our bodies to function properly. However, errors in these processes can lead to protein clumps that impair functionality, underpinning a variety of neurodegenerative disorders affecting the brain, including Alzheimer's and dementia. Understanding why this clumping occurs and how to treat it has remained elusive, largely due to a lack of adequate tools to study these phenomena. Researchers have now introduced a groundbreaking tool that can find these tiny protein clumps in microscopy images and lead to improved understanding and treatments of diseases like cancer, Alzheimer's, and Parkinson's.

Scientists at the University of Copenhagen (Copenhagen, Denmark) have developed a machine learning algorithm capable of observing protein clumping in real time under a microscope. This algorithm is capable of automatically identifying and monitoring the critical characteristics of the clumped-up building blocks responsible for Alzheimer's and other neurodegenerative diseases—a task previously unachievable. It can detect protein clumps as small as a billionth of a meter in microscopy images and categorize these clumps by their shape and size while tracking their development. The physical appearance of these clumps significantly influences their function and behavior within the body, whether detrimental or beneficial.

Going forward, this algorithm will simplify the process of discovering why clumps form, thereby aiding the development of new medications and therapies to fight these debilitating disorders. The researchers are actively using this tool in experiments with insulin molecules, which, when clumped, lose their ability to regulate blood sugar effectively. The tool allows for the observation of how these clumps change when exposed to various compounds, paving the way to potentially halt or alter them into less harmful or more stable forms. The team is optimistic about the tool's potential to facilitate drug development once these tiny building blocks are precisely identified. They anticipate that their efforts will initiate the gathering of more comprehensive knowledge regarding the shapes and functions of proteins and molecules. The algorithm is accessible as open-source software on the internet for use by scientific researchers and others interested in exploring the clumping of proteins and other molecules.

"In just minutes, our algorithm solves a challenge that would take researchers several weeks. That it will now be easier to study microscopic images of clumping proteins will hopefully contribute to our knowledge, and in the long term, lead to new therapies for neurodegenerative brain disorders," said PhD Jacob Kæstel-Hansen, who led the research team behind the algorithm.

Related Links:
University of Copenhagen


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.